Author(s):
Dhivya K, Umaparvathy S, Jayaraj R R, Selva Priya M
Email(s):
divyapharmd@gmail.com
DOI:
10.52711/0974-360X.2022.00361 
Address:
Dhivya K1, Umaparvathy S2, Jayaraj R R2, Selva Priya M2
1Department of Pharmacy Practice, C.L. Baid Metha College of Pharmacy, Chennai.
2Department of Pharmaceutical Analysis, K.K. College of Pharmacy, Chennai.
*Corresponding Author
Published In:
Volume - 15,
Issue - 5,
Year - 2022
ABSTRACT:
Oral hygiene plays a critical role in whole-body health. Periodontitis is a chronic inflammatory disease that damages the soft tissue and destroys the bone that supports your teeth. Periodontitis can cause teeth to loosen or lead to tooth loss. Various clinical studies have shown distinct relationships between elevated serum C- reactive protein (CRP), lipid level and chronic periodontitis. Elevated CRP coupled with chronic infections like periodontitis is associated with chronic heart diseases, thus making periodontitis as one of the major risk factors for cardiovascular diseases. Therefore, the study was designed to determine the effect of periodontal treatment on serum lipid and CRP levels in type-II diabetic patients with chronic periodontitis. This prospective observational study was carried out in the dental department of a tertiary care hospital for a period of 6 months. Clinical and biochemistry reports of 90 patients were collected in designed case report forms. All statistical analyses were performed using IBM Statistical Package for Social Sciences (SPSS) 17. Significant reduction in all the clinical and dental parameters was comparatively higher in patients who received azithromycin than in patients who received metronidazole and scaling and root planing (SRP) alone. Hence, treating chronic Periodontitis with antibiotics impediments the complication of developing cardiovascular disease.
Cite this article:
Dhivya K, Umaparvathy S, Jayaraj R R, Selva Priya M. The Synergistic effect of Oral Antibiotic Therapy on C- Reactive Protein and Lipid profile in Chronic Periodontitis patients. Research Journal of Pharmacy and Technology. 2022; 15(5):2172-5. doi: 10.52711/0974-360X.2022.00361
Cite(Electronic):
Dhivya K, Umaparvathy S, Jayaraj R R, Selva Priya M. The Synergistic effect of Oral Antibiotic Therapy on C- Reactive Protein and Lipid profile in Chronic Periodontitis patients. Research Journal of Pharmacy and Technology. 2022; 15(5):2172-5. doi: 10.52711/0974-360X.2022.00361 Available on: https://rjptonline.org/AbstractView.aspx?PID=2022-15-5-43
REFERENCES:
1. Dr. Janhvi Manohar, Dr Asha. Anti-protease activity of lavender on chronic periodontitis patients – an ex-vivo study. Asian J Pharm Res 2020; 10(2):95-100. 10.5958/2231-5691.2020.00018.0
2. Gayathri M, Dr Gheena S, Gopinath. Comparison of the aerobic microbes in supragingival plaque of chronic and aggressive periodontitis patients. Research J Pharm and Tech 2016; 9(9):1363-6. 10.5958/0974-360X.2016.00261.4
3. Ruchika A, Lakshmi T. Salivary enzymes as biomarkers for periodontitis – an update. Research J Pharm and Tech 2014; 7(1):98-100.
4. Shrada BK. Occurrence of bacteremia in patients with chronic periodontitis. Research J Pharm and Tech 2015; 8(11):1605-6. 10.5958/0974-360X.2015.00285.1
5. Mounika S, Gopinath. Periodontitis as a risk factor of atherosclerosis. Research J Pharm and Tech 2016; 9(11):2017-9.
6. Remal Abdulaziz Asaad. Hormone receptor status and its relation to c-reactive protein and other prognostic factors in breast cancer in Jableh- Syria. Research J Pharm and Tech 2017; 10(9): 3003-10. 10.5958/0974-360X.2017.00532.7
7. Karthikeyan MK, Sheeja V. Effect of nonsurgical periodontal therapy on serum lipid profile- prospective study. Research J Pharm and Tech 2019; 12(8):3664-8. 10.5958/0974-360X.2019.00625.5
8. D'Aiuto F, Nibali L, Parkar M, Suvan J, Tonetti MS. Short-term effects of intensive periodontal therapy on serum inflammatory markers and cholesterol. J Dent Res 2005; 84(3):269- agents in the management of periodontal disease: a review 73. 10.1177/154405910508400312
9. Ramamoorthy RD, Nallasamy V, Reddy R, Esther N, Maruthappan Y. A review of C-reactive protein: A diagnostic indicator in periodontal medicine. J Pharm Bioallied Sci 2012; 4(2): S422-6. 10.4103/0975-7406.100318
10. Gaurav T, Ruchi T, Brijendra S, Awani KR. Design and evaluation of target retentive device containing metronidazole for the treatment of periodontal disease. Research J Pharm. and Tech 2008;1(4):390-4.
11. Waghmare Sneha S, Kadam Trupti V, Darekar AB, Saudagar RB. Anti-infective agents in the Management of Periodontal Disease: A Review. Res. J Pharm Dosage Form and Tech 2015;7(1):82-9. 10.5958/0975-4377.2015.00012.9
12. Shaddox LM, Walker CB. Treating chronic periodontitis: current status, challenges, and future directions. Clin Cosmet Investig Dent 2010; 2:79-91.
13. Dastoor SF, Travan S, Neiva RF, Rayburn LA, Giannobile WV, Wang HL. Effect of adjunctive systemic azithromycin with periodontal surgery in the treatment of chronic periodontitis in smokers: a pilot study. J Periodontol 2007; 78(10): 1887-96. 10.1902/jop.2007.070072
14. Lai PC, Ho W, Jain N, Walters JD. Azithromycin Concentrations in Blood and Gingival Crevicular Fluid after Systemic Administration. J Periodontol 2011; 82(11): 1582-6. 10.1902/jop.2011.110012
15. Etemadifar R, Konarizadeh S, Zarei A, Farshidi H, Sobhani A. Relationship between periodontal status and C-reactive protein and interleuckin-6 levels among atherosclerotic patients in Bandar Abbas, Iran in 2014. Electron Physician. 2015; 7(1):1010-6. 10.14661/2015.1010-1016
16. Jyotsna S, Priyalochana G. Role of Interleukin 1 in serum in Chronic Periodontitis -A Review. Research J Pharm and Tech 2017; 10(11): 4090-2. 10.5958/0974-360X.2017.00741.7
17. Pussinen PJ, Jauhiainen M, Vilkuna-Rautiainen T, Sundvall J, Vesanen M, Mattila K, et al. Periodontitis decreases the antiatherogenic potency of high-density lipoprotein. J Lipid Res 2004; 45(1):139-47. 10.1194/jlr.M300250-JLR200